
Titan Pharmaceuticals Inc
NASDAQ:TTNP

Fundamental Analysis


Revenue & Expenses Breakdown
Titan Pharmaceuticals Inc
Balance Sheet Decomposition
Titan Pharmaceuticals Inc
Current Assets | 2.9m |
Cash & Short-Term Investments | 2.8m |
Receivables | 62k |
Other Current Assets | 30k |
Free Cash Flow Analysis
Titan Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Titan Pharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-4.6m
USD
|
Operating Income
|
-4.6m
USD
|
Other Expenses
|
-149k
USD
|
Net Income
|
-4.7m
USD
|
TTNP Profitability Score
Profitability Due Diligence
Titan Pharmaceuticals Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Score
Titan Pharmaceuticals Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
TTNP Solvency Score
Solvency Due Diligence
Titan Pharmaceuticals Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Score
Titan Pharmaceuticals Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TTNP Price Targets Summary
Titan Pharmaceuticals Inc
Dividends
Current shareholder yield for TTNP is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?